Cheng, Jie-Jun <br/><br/>
Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.  [electronic resource] 

 -  Acta radiologica (Stockholm, Sweden : 1987)  Oct 2012 
 - 900-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0455 
<br/><br/><label>Standard No.: </label>10.1258/ar.2012.110017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Rectal<br/>Animals<br/>Cell Survival<br/>Chitosan--pharmacokinetics<br/>Colon--cytology<br/>Contrast Media--pharmacokinetics<br/>Feasibility Studies<br/>Gadolinium DTPA--pharmacokinetics<br/>HeLa Cells<br/>Humans<br/>Image Enhancement--methods<br/>Intestinal Absorption<br/>Intestinal Mucosa--metabolism<br/>Magnetic Resonance Imaging<br/>Male<br/>Nanoparticles--toxicity<br/>Random Allocation<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reference Values